CMTDIG

NEFL | 2004

What Is CMTDIG?

CMTDIG is a type of CMT caused by autosomal dominant mutations in the NEFL gene. This gene provides instructions for making neurofilament light chain, a structural protein that helps maintain the size and shape of nerve axons. Mutations in the NEFL gene disrupt this function, leading to impaired nerve signal transmission.

CMTDIG is autosomal dominant, meaning that just one of the gene’s two copies needs a mutation to cause this subtype.

Clinical Features

The age of symptom onset in CMTDIG is variable, ranging from childhood to adulthood. Symptoms typically begin in the lower extremities and progress over time to involve the upper limbs. Nerve conduction studies usually show somewhat slowed conduction velocities, consistent with an intermediate form of CMT.

CMTDIG symptoms may include:

  • Weakness in the feet and lower legs
  • Muscle atrophy
  • Foot drop
  • Reduced or absent reflexes
  • Reduced sensation
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands and forearms
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

CMTDIG shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
CMTDIG

Classification
CMTDI

Neuropathy Type
Intermediate

Inheritance Pattern
autosomal dominant

Genetic Context

HGNC-Approved Gene Symbol
NEFL

Gene Full Name
neurofilament light chain

HGNC Gene Alias(es)
NFL, NF68

Chromosome
8p21.2

Zygosity of Responsible Variant
Heterozygous

Variant Mechanism

Dominant-Negative

Details

Confidence:
High

Prediction:
Functional and genetic evidence supports a dominant-negative mechanism for CMTDIG: neurofilaments are obligate copolymers nucleated by the light chain, and mutant NF-L from the dominant NEFL alleles co-assembles with normal subunits, blocks filament formation, and forms aggregates that stall axonal transport. Wild-type subunits supplied alongside are drawn into those aggregates rather than rescuing assembly. Biallelic NEFL null alleles instead cause the recessive subtype CMT2B5, a true loss of light chain.

Rationale:
Cooperative assembly is why one abnormal subunit costs more than a missing one: mutant NF-L is incorporated at the nucleation step and takes normal subunits with it, so a neuron loses far more filament than a halved gene dose would cost. Patients who make no light chain at all have the distinct recessive disease CMT2B5.

ClinVar Pathogenic Variants

View NEFL ClinVar Variants

CMTDIG OMIM Entry

CMTDIG OMIM

NEFL OMIM Entry

NEFL OMIM

More Info

CMTDIG Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

The Novel Neurofilament Light (NEFL) Mutation Glu397Lys is Associated With a Clinically and Morphologically Heterogeneous Type of Charcot-Marie-Tooth Neuropathy

Authors

Züchner, S., Vorgerd, M., Sindern, E., & Schröder, J. M.

Publication Date
February 1, 2004

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.